UAB Spinoff Targets Cancer with Drug-Resistant Immunotherapy, a Novel Approach to Fighting Tumors
University of Alabama at BirminghamThe University of Alabama at Birmingham and two partner institutions have received a European patent for their novel approach to fighting cancer, an approach that is led by the UAB spinoff biopharmaceutical company Incysus Ltd.